Avantor, Inc.
General ticker "AVTR" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $7.0B (TTM average)
Avantor, Inc. follows the US Stock Market performance with the rate: 24.5%.
Estimated limits based on current volatility of 1.4%: low 14.87$, high 15.28$
Factors to consider:
- Total employees count: 13500 (0.0%) as of 2025
- US accounted for 52.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Supply chain disruptions, Operational and conduct risks, Inflationary pressures, Market competition, Acquisition/divestiture risks
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.43$, 14.42$]
- 2026-12-31 to 2027-12-31 estimated range: [9.21$, 15.36$]
Financial Metrics affecting the AVTR estimates:
- Positive: with PPE of 12.5 at the end of fiscal year the price was neutral
- Positive: 6.77 < Operating cash flow per share per price, % of 8.10
- Negative: Investing cash flow per share per price, % of -1.69 <= -1.23
- Positive: -13.52 < Operating profit margin, % of -3.62
- Negative: Industry operating cash flow per share per price (median), % of 1.58 <= 3.66
- Positive: -16.84 < Industry operating profit margin (median), % of -7.42
- Negative: 1.42 < Interest expense per share per price, % of 2.20
- Positive: -7.72 < Return on assets ratio (scaled to [-100,100]) of -4.30
Short-term AVTR quotes
Long-term AVTR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $6,967.20MM | $7,230.20MM | $6,547.10MM |
| Operating Expenses | $6,270.80MM | $6,145.40MM | $6,793.30MM |
| Operating Income | $696.40MM | $1,084.80MM | $-246.20MM |
| Non-Operating Income | $-285.90MM | $-230.90MM | $-195.10MM |
| Interest Expense | $284.80MM | $218.80MM | $169.80MM |
| Income(Loss) | $410.50MM | $853.90MM | $-441.30MM |
| Taxes | $89.40MM | $142.40MM | $88.90MM |
| Net Income(Loss)* | $321.10MM | $711.50MM | $-530.20MM |
| Stockholders Equity | $5,252.60MM | $5,956.70MM | $5,565.00MM |
| Inventory | $828.10MM | $731.50MM | $818.20MM |
| Assets | $12,972.70MM | $12,114.50MM | $11,794.70MM |
| Operating Cash Flow | $870.00MM | $840.80MM | $623.80MM |
| Capital expenditure | $146.40MM | $148.80MM | $128.80MM |
| Investing Cash Flow | $-143.70MM | $438.90MM | $-130.50MM |
| Financing Cash Flow | $-843.70MM | $-1,281.20MM | $-409.40MM |
| Earnings Per Share** | $0.48 | $1.05 | $-0.78 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.